Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire

Journal of Infectious Diseases

Volumn 177, Issue 3, 1998, Pages 579-585

  Gea Banacloche, Juan C ^a   Weiskopf, Emma E ^a   Hallahan, Claire ^a   De Quirós, Juan Carlos López Bernaldo ^a   Flanigan, Mark ^a   Mican, Joann M ^a   Falloon, Judith ^a   Baseler, Michael ^a   Stevens, Randy ^a   Clifford Lane, H ^a   Connors, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENTARY DNA; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 17344368991     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514233     Document Type: Article

References (26)

1. Lane HC, Masur H, Edgard LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453.
2. Sabbaj S, Para MF, Pass RJ, Adams PW, Orosz CG, Whitacre CC. Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J Clin Immunol 1992;12:216-24.
3. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-9.
4. Arden B, Clark SP, Kabelitz D, Mak TW. Human T-cell receptor variable gene segment families. Immunogenetics 1995;42:455-500.
5. LaRocque R, Robinson MA. Diversity in the human T cell receptor β chain. Hum Immunol 1996;48:3-11.
6. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16:176-81.
7. Currier JR, Deulofeut H, Barron KS, Kehn PJ, Robinson MA. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum Immunol 1996;48:39-51.
8. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993;90:4319-23.
9. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilskky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994;153:2807-18.
10. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997;3:533-40.
11. Pannetier C, Levraud JP, Lim A, Even J, Kourilsky P. The immunoscope approach for the analysis of T-cell repertoires. In: Oksenberg J, ed. The human antigen T-cell receptor: selected protocols and applications. New York: Chapman & Hall, 1997.
12. Genevee C, Diu A, Nierat J, et al. An experimentally validated panel of subfamily-specific oligonucleotide primers (Va1-w29/Vb1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992;22:1261-9.
13. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1989;86:8941-5.
14. Imberti L, Sottini A, Bettinardi A, Pouti M, Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 1991;254:860-2.
15. + T cells. AIDS 1993;7:633-8.
16. Dalgleish AG, Wilson S, Gompels M, et al. T-cell receptor variable gene products and early HIV-1. Lancet 1992;339:824-8.
17. McCoy JP Jr, Overton WR, Blumstein L, Baxter JD, Gekowski KM, Donaldson MH. Alterations of T-cell receptor variable region expression in human immunodeficiency virus disease. Cytometry 1995;22:1-9.
18. + T cells of human immunodeficiency virus-infected infants. Eur J Immunol 1993; 23:2041-4.
19. Soudeyns H, Rebai N, Pantaleo GP, et al. The T cell receptor V β repertoire in HIV-1 infection and disease. Semin Immunol 1993;5:175-85.
20. + T cells of the virus-positive twins. Proc Natl Acad Sci USA 1994;91:1529-33.
21. Lane HC, Depper JM, Greene WC, Whalen G, Walsmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985;313:79-84.
22. + cell numbers and clinical staging. J Clin Invest 1989;84:1892-9.
23. + T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997; 99:1739-50.
24. Horsburgh CR Jr, Hanson DL, Jones JL, Thompson SE III. Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis. J Infect Dis 1996;174:1212-7.
25. Lederman M, Connick E, Landay A, et al. Partial immune reconstitution after 12 weeks of HAART (AZT, 3TC, ritonavir). Preliminary results of ACTG 315 [abstract LB13]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC, 22-26 January 1997). Alexandria, VA: Infectious Diseases Society of America, 1997:208.
26. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-6.